Cerebrovascular Disease

  • Frances E. Jensen
  • Mark A. Creager


Stroke remains the third leading cause of death in the United States, with approximately 500,000 new stroke cases reported each year [1]. The term stroke encompasses both hypoxic/ischemic brain infarction as well as a variety of hemorrhagic conditions, including hypertensive intracerebral hemorrhage, subarachnoid hemorrhage, and hemorrhage related to arteriovenous malformation rupture.


Atrial Fibrillation Transient Ischemic Attack Carotid Endarterectomy Carotid Stenosis Carotid Artery Stenting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American Heart Association: 2001 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2001.Google Scholar
  2. 2.
    Norris JW, Zhu CZ, Bornstein NM, Chambers BR: Vascular risks of asymptomatic carotid stenosis. Stroke 1991, 22: 1485–1490.PubMedCrossRefGoogle Scholar
  3. 3.
    Jensen FE: Cerebrovascular disease. In Textbook of Vascular Medicine, edn 2. Edited by Loscalzo J, Creager MA, Dzau VJ. Boston: Little, Brown; 1996: 781–795.Google Scholar
  4. 4.
    Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324: 71–86.CrossRefGoogle Scholar
  5. 5.
    Albers GW, Amarenco P, Easton JD, et al.: Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001, 119:300S–320S.Google Scholar
  6. 6.
    Mohr JP, Thompson JLP, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl JMed 2001, 345:1444–1451.Google Scholar
  7. 7.
    The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997, 349:1569–1581.Google Scholar
  8. 8.
    CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997, 349:1641–1649Google Scholar
  9. 9.
    Wardlaw JM: Overview of Cochrane thrombolysis meta-analysis. Neurology 2001, 57: S69 - S76.PubMedCrossRefGoogle Scholar
  10. 10.
    Mohler ER III, Delanty N, Rader DJ, Raps EC: Statins and cerebrovascular disease: plaque attack to prevent brain attack. Vasc Med 1999, 4: 269–272.PubMedCrossRefGoogle Scholar
  11. 11.
    Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991, 325: 445–453.CrossRefGoogle Scholar
  12. 12.
    MRC European Carotid Surgery Trial: interim results from symptomatic patients with severe (70–99%) or mild (0–29%) carotid stenosis. Lancet 1991, 337:1235–1243.Google Scholar
  13. 13.
    Mayberg MR, Wilson SE, Yatsu F, et al.,for the Veterans Affairs Cooperative Studies Program 309 Trialist Group: Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991, 266:3289–3294.Google Scholar
  14. 14.
    Whittemore AD, Mannick JA: Principles of vascular surgery. In Textbook of Vascular Medicine, edn 2. Edited by Loscaizo J, Creager MA, Dzau VJ. Boston: Little, Brown and Co.; 1996: 675–702.Google Scholar
  15. 15.
    Hobson RW, Weiss DG, Fields WS, et al.: Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1991, 328:221–227.Google Scholar
  16. 16.
    Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995, 273: 1421–1428.CrossRefGoogle Scholar
  17. 17.
    Roubin GS, New G, Iyer SS, et al.: Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001, 103:532–537.Google Scholar
  18. 18.
    Caplan LR Vertebrobasilar system syndromes. In Handbook of Clinical Neurology, vol 53, Vascular Diseases. Part I. Edited by Toole JE. Amsterdam: Elsevier; 1988: 371–408.Google Scholar
  19. 19.
    Cardiogenic brain embolism. Cerebral Embolism Task Force.Arch Neurol 1986, 43: 71–84.Google Scholar
  20. 20.
    Wolf PA, Abbott RD, Karulel WB: Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987, 147: 1561–1564.PubMedCrossRefGoogle Scholar
  21. 21.
    Kannel WB, Abbott RD, Savage DD, et al.: Coronary heart disease and atrial fibrillation. Am Heart J 1983, 106: 389–396.PubMedCrossRefGoogle Scholar
  22. 22.
    Preliminary report of the Stroke Prevention in Atrial Fibrillation study. N Engl J Med 1990, 322: 863–868.CrossRefGoogle Scholar
  23. 23.
    Stroke Prevention in Atrial Fibrillation study: final results. Circulation 1991, 84:527–539.Google Scholar
  24. 24.
    The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 1990, 323: 1505–1511.CrossRefGoogle Scholar
  25. 25.
    Petersen P, Boysen G, Godtfredsen J, et al.: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet 1989, 1:175–179.Google Scholar
  26. 26.
    Ezekowitz MD, Bridgers SL, James KE, et al.: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1992, 327:1406–1412.Google Scholar
  27. 27.
    Petersen P: Anticoagulant therapy for atrial fibrillation. In Atrial Fibrillation: Mechanisms and Management. Edited by Falk RH, Podrid PJ. New York: Raven Press; 1992: 307–319.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Frances E. Jensen
  • Mark A. Creager

There are no affiliations available

Personalised recommendations